AmpliPhi Biosciences
Develops bacteriophage-based therapies targeting antibiotic-resistant infections, with a focus on precision antimicrobials for critical care.
HQ location
Los Angeles, United States
Launch date
Employees
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | Merger | |
| Total Funding | 000k | ||
University of Pittsburgh(exited)
ROTH Capital Partners(exited)
RA Capital Management(exited)
BioScience Managers Limited(exited)
Third Security LLC(exited)
Venrock(exited)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by AmpliPhi Biosciences
EditACQUISITION by AmpliPhi Biosciences Jan 2011
ACQUISITION by AmpliPhi Biosciences Jan 2016